New York Cannabis Giant Has A New Name And Brand Identity
Publicly-traded cannabis company Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) confirmed Monday its change in legal name to The Cannabist Company Holdings Inc. and will rebrand to The Cannabist Company.
Publicly-Traded Vape-Tech Company Posts 100.4% YoY Growth In Revenue For Pot Products
Vape-tech company Ispire Technology Inc. (NASDAQ: ISPR) reported Monday financial results for the fiscal year 2023, which ended on June 30, 2023 revealing 100.4% growth in revenue from cannabis products year-over-year, reaching $40 million.
EXCLUSIVE: Better For You Wellness To Acquire Ideation Lab, Jordre Well And Its Signature CBD Coffee Brand
Better For You Wellness, Inc. (OTCQB: BFYW), an Ohio-based wellness company at the forefront of plant-based and science-driven innovations in the rapidly expanding $1.5 trillion wellness industry has entered into a binding Membership Interest Purchase Agreement (MIPA) with The Ideation Lab (TIL) LLC
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland’s Consumption Site & More
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next
Cannabis Stock Movers For September 18, 2023
GAINERS: EVIO (OTC:EVIO) shares closed up 4900.00% at $5e-05 1933 Industries (OTC:TGIFF) shares closed up 14.56% at $0.02…
Cannabis Chart Of The Week: How Much Will MSOs Save In Taxes From Elimination Of 280e?
One of the most important results of the potential rescheduling of cannabis to Schedule 3 is eliminating 280e taxes. In previous charts of the week, we have shown that 280e significantly negatively impacts cannabis companies by reducing their internally funded growth and limiting their debt capacity.
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic compound aimed at treating postpartum depression (PPD.)
Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie’s $100M Pledge Update
Billionaire hedge fund and NY Mets owner, Steve Cohen amped up his support for psychedelics R&D through a new investment of nearly $19 million in beneficially owned shares of Cybin Inc. (NYSE: CYBN).
Curaleaf Arizona Workers Rally For Rights On Heels Of Teamster Success In Cannabis Sector
On Friday, a peaceful rally organized by United Food & Commercial Workers Local 99, a private-sector union, advocated for the rights of the striking workers at Curaleaf Holdings, Inc.'s (CSE: CURA) (OTCQX: CURLF) cannabis<